832-497-2220 [email protected]

Wearable Medical Device

Introductions of Selected Companies

Guangzhou Pharmaceutical Holdings Limited

Guangzhou Pharmaceutical Holdings Limited (GPHL) is a wholly state-owned enterprise authorized by Guangzhou municipal government to operate state-owned assets. GPHL is dedicated to the research and development of Chinese patent medicine, Chinese Herbal Medicine, chemical-pharmaceutical raw materials and preparations, biological Medicine and healthcare products, and pharmaceutical logistics and distribution and healthcare service.

As a large enterprise winning the municipal government’s key support for development, GPHL integrates the research, manufacturing, and trading of medicine. It consists of one public company, namely Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., which is listed both at the Stock Exchange of Hong Kong Limited (H-Shares) and the Shanghai Stock Exchange (A-Shares), and around 30 subsidiaries.

With a history of 419 years, GPHL has ranked first on the list of China’s top 100 Pharmaceutical Companies for seven consecutive years since 2012 and ranked 165th on the list of China’s Top 500 Enterprises in 2018. The group achieved a sales revenue of over 100 billion yuan in 2017 and 116 billion yuan in 2018, making it the second state-owned enterprise in Guangzhou to record such an achievement.

Established in 1600, Chenliji Pharmaceutical Factory is known as the “World’s Oldest Operating Pharmaceutical Factory” affiliated to GPHL and has been widely recognized as a leading China’s Time-honored Brand pharmaceutical enterprise in southern China.

 Neusoft Medical

Neusoft Medical Systems Co., Ltd. (Neusoft Medical) is a leading global clinical diagnosis and treatment, solution provider headquartered in China, with subsidiaries in the United States, Dubai, Peru, Russia, Brazil, Kenya, Germany, Korea, Thailand, and a representative office in Vietnam.

Neusoft Medical is continuously innovating its portfolio of medical imaging diagnosis and clinical solutions in CT, MRI, DSA, XR, PET/CT, RT, US, and IVD. Neusoft Medical also is developing MDaaS (Medical Devices & Data as a Service), a strategic product line built using the Internet, big data, artificial intelligence, combined with other technologies improving medical institutions’ ability to diagnose and treat patients, achieving operational excellence.

Innovation is always the driving force of Neusoft Medical. The global R&D centers are located in Houston, Seoul, Beijing, Shanghai, Shenyang, Guangzhou, and Nanjing. Neusoft Medical is collaborating with global scientists and medical institutions dedicated to advancing the technology of medical imaging solutions.

Together with 38,000 installations in more than 100 countries, Neusoft Medical provides advanced, high-quality medical imaging solutions to patients around the world.

Listed are only a few corporate partners, for information on more potential partners, please contact us directly.